The abstract is read at the publisher; the summary is JClub's.
In coronary artery bypass graft surgery patients, CHIP in blood (7.9%) is dominated by DNMT3A/TET2/ASXL1, while arterial CHIP-associated mutations show a distinct CALR/SETDB1/PDSS2 profile.
- Why it matters: Peripheral blood evidence for CHIP in coronary artery disease may not reflect what occurs in arterial tissue, and it is unclear whether hematopoietic clones appear in the arterial compartment.
- What they did: Deep whole-exome sequencing was performed on 302 blood granulocytes and 263 arterial tissues (221 matched pairs) at mean depths of 130.5X and 120.8X, with regression testing links to age and SYNTAX score.
- The result: Blood CHIP carrier status increased with age (beta=0.07, p=0.02) and was linked to lower SYNTAX score (beta=-1.05, p=2.66 x 10-3), while arterial CALR mutations were linked to higher SYNTAX score (beta=1.14, p=0.03); only four identical variants were shared across compartments.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.